Clinical trials
Withdrawn Phase 1/2 Squamous Cell Carcinoma of Head and Neck trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centre Antoine Lacassagne | 1 |
| Dana-Farber Cancer Institute | 1 |
| ImmunityBio, Inc. | 1 |
| M.D. Anderson Cancer Center | 1 |
| NKGen Biotech, Inc. | 1 |
| National Cancer Institute (NCI) | 1 |
| Novartis Pharmaceuticals | 1 |
| Rain Oncology Inc | 1 |
| Silverback Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Squamous Cell Carcinoma of Head and Neck | 9 |
| Breast Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Head and Neck Neoplasms | 2 |
| Stomach Neoplasms | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Carcinoma, Renal Cell | 1 |
| Carcinoma, Transitional Cell | 1 |
| Colorectal Neoplasms | 1 |
| Endometrial Neoplasms | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.